ArticleBiology2026
Evaluation of the In Vivo Antioxidant Capacity of Sheep Hemoglobin Hydrolysate in a Rat Model.
Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Sheep hemoglobin hydrolysate (SHH) has important biological antioxidant functions. However, the specific mechanism is not well understood. The aim of this study was to investigate the antioxidant activity of SHH in vivo and its potential mechanism. Eighteen Sprague Dawley rats were randomly divided into DG (gavaged with 0.9% saline), VC (gavaged with vitamin C 100 mg/kg BW) and SHH (gavaged with SHH 800 mg/kg BW) groups. The rats were given intragastric administration for 21 days. On the 22nd day, all rats were intraperitoneally injected with diquat as a challenge. The results showed that SHH treatment had no obvious effect on the growth performance and main organ index of rats after the diquat challenge. Compared to the DG group, the SHH group maintained higher serum T-AOC and GSH-Px levels after the diquat challenge. SHH significantly increased GSH-Px activity in the liver and kidney, and decreased MDA content in the kidney after the diquat challenge. SHH significantly up-regulated the gene expression of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.